Why and how should we measure disease activity and damage in lupus?

Presse Medicale

Volumn 43, Issue 6P2, 2014, Pages

  Feld, Joy ^a   Isenberg, David ^b  

^a Rheumatology Unit   (Israel)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CLINICAL FEATURE; DECISION MAKING; DISEASE ACTIVITY; DISEASE ASSOCIATION; HEALTH STATUS; HUMAN; LUPUS VULGARIS; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; QUALITY OF LIFE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; VALIDITY; BRITISH ISLES LUPUS ASSESSMENT GROUP INDEX; DISEASE EXACERBATION; EUROPEAN CONSENSUS LUPUS ACTIVITY MEASURE; HEALTH ASSESSMENT QUESTIONNAIRE; MUSCULOSKELETAL DISEASE ASSESSMENT; PROGNOSIS; REMISSION; SELENA SLEDAI; SHORT FORM 36; SLE RESPONDER INDEX; SLEDAI; SLEDAI 2K; SYSTEMIC LUPUS ACTIVITY MEASURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

COST OF ILLNESS; DISEASE PROGRESSION; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATIENT ACUITY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84902549010     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2014.03.002     Document Type: Short Survey

References (31)

1. Symmons D.P., Coppock J.S., Bacon P.A., Bresnihan B., Isenberg D.A., Maddison P., et al. Development of a computerized index of clinical disease activity in systemic lupus erythematosus. Q J Med 1988, 69:927-932.
2. Isenberg D.A., Rahman A., Allen E., Farewell V., Akil M., Bruce I.N., et al. BILAG 2004: development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005, 44:902-906.
3. Liang M.H., Sacher S.A., Roberts W.N., Esdaile J.M. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988, 31:817-825.
4. Bencivelli W., Vitali C., Isenberg D.A., Smolen J.S., Snaith M.L., Sciuto M., et al. Disease activity in systemic lupus erythematosus: report of the consensus study group of the European workshop for rheumatology research. III. Development of a computerised clinical chart and its application to the comparison clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 1992, 10:549-554.
5. Bombardieri S., Vitali C., Caponi L., Manca L., Bencivelli W. Activity criteria in systemic lupus erythematosus. Clin Exp Rheumatol 1994, 12:S45-S48.
6. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang D.H., the Committee on Prognosis Studies in SLE Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992, 35:630-640.
7. Committee on Prognosis Studies Prognosis studies in SLE: an activity index [abstract]. Arthritis Rheum 1986, 29 Suppl.:S93.
8. Yee C.S., Farewell V., Isenberg D.A., Rahman A., Teh L.S., Griffiths B., et al. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 2007, 56:4113-4119.
9. Yee C.S., Farewell V., Isenberg D.A., Prabu A., Sokoll K., Teh L.S., et al. Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity. Arthritis Rheum 2006, 54:3300-3305.
10. Yee C.S., Farewell V., Isenberg D.A., Griffiths B., Teh L.S., Bruce I.N., et al. The BILAG 2004 index is sensitive to change for assessment of SLE disease activity. Rheumatology (Oxford) 2009, 48:691-695.
11. Griffiths B., Mosca M., Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 2005, 19:685-708.
12. Gladman D.D., Goldsmith C.H., Urowitz M.B., Bacon P., Bombardier C., Isenberg D., et al. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 1992, 19:608-611.
13. Ward M.M., Marx A.S., Barry N.N. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 2000, 27:664-670.
14. Gladman D.D., Ibañez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002, 29:288-291.
15. Touma Z., Urowitz M.B., Fortin P.R., Landolt C., Toloza S.M., Riddell C., et al. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity. J Rheumatol 2011, 38:868-873.
16. Isenberg D.A. Rhubarb and reliability-a Jane Austen view of systemic lupus erythematosus. J Rheumatol 2013, 40:7-8.
17. Petri M., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., Sammaritano L.R., et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005, 353:2550-2558.
18. Sanchez-Guerrero J., Uribe A.G., Jimenez-Santana L., Mestanza-Peralta M., Lara-Reves P., Seuc A.H., et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005, 353:2539-2549.
19. Isenberg D.A., Allen E., Farewell V., D'Cruz D., Alarc'on G.S., Aranow C., et al. An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis 2011, 70:54-59.
20. Lateef A., Petri M. Unmet medical needs in systemic lupus erythematosus. Arthritis Res Ther 2012, 14. S4:1-9.
21. Romero-Diaz J., Isenberg D., Ramsey-Goldman R. Measures of adult systemic lupus erythematosus. Arthritis Care Res 2011, 63:S37-S46.
22. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996, 39:363-369.
23. Stoll T., Sutcliffe N., Klaghofer R., Isenberg D. Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage? A prospective study. Ann Rheum Dis 2000, 59:832-835.
24. Rahman P., Gladman D.D., Urowitz M.B., Hallett D., Tam L.S. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001, 10:93-96.
25. Fernando M.M.A., Isenberg D. How to monitor SLE in routine clinical practice. Ann Rheum Dis 2005, 64:524-527.
26. Lattanzi B., Consolaro A., Solari N., Ruperto N., Martini A., Ravelli A. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI). Arthritis Care Res 2011, 63:S112-S117.
27. McElhone K., Abbott J., Shelmerdine J., Bruce I.N., Ahmad Y., Gordon C., et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007, 57:972-979.
28. Leong K.P., Kong K.O., Thong B.Y., Koh E.T., Lian T.Y., Teh C.L., et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford) 2005, 44:1267-1276.
29. Doward L.C., McKenna S.P., Whalley D., Tennant A., Griffiths B., Emery P., et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009, 68:196-200.
30. Yazdany J. Health-related quality of life measurement in systemic lupus erythematosus: The LupusQoL, SLEQoL, and L-QoL. Arthritis Care Res 2011, 63:S413-S419.
31. Mina R., Klein-Gitelman M.S., Ravelli M., Beresford M.W., Avcin T., Espada G., et al. Inactive disease and remission in childhood-onset systemic lupus erythematosus. Arthritis Care Res 2012, 64:683-693.